Canadian cancer risk management model: Evaluation of cancer control

William K. Evans, Michael C. Wolfson, William M. Flanagan, Janey Shin, John Goffin, Anthony B. Miller, Keiko Asakawa, Craig Earle, Nicole Mittmann, Lee Fairclough, Jillian Oderkirk, Philippe Finès, Stephen Gribble, Jeffrey S Hoch, Chantal Hicks, D. Walter R Omariba, Edward Ng

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Objectives: The aim of this study was to develop a decision support tool to assess the potential benefits and costs of new healthcare interventions. Methods: The Canadian Partnership Against Cancer (CPAC) commissioned the development of a Cancer Risk Management Model (CRMM)-a computer microsimulation model that simulates individual lives one at a time, from birth to death, taking account of Canadian demographic and labor force characteristics, risk factor exposures, and health histories. Information from all the simulated lives is combined to produce aggregate measures of health outcomes for the population or for particular subpopulations. Results: The CRMM can project the population health and economic impacts of cancer control programs in Canada and the impacts of major risk factors, cancer prevention, and screening programs and new cancer treatments on population health and costs to the healthcare system. It estimates both the direct costs of medical care, as well as lost earnings and impacts on tax revenues. The lung and colorectal modules are available through the CPAC Web site (www.cancerview.ca/cancerrriskmanagement) to registered users where structured scenarios can be explored for their projected impacts. Advanced users will be able to specify new scenarios or change existing modules by varying input parameters or by accessing open source code. Model development is now being extended to cervical and breast cancers.

Original languageEnglish (US)
Pages (from-to)131-139
Number of pages9
JournalInternational Journal of Technology Assessment in Health Care
Volume29
Issue number2
DOIs
StatePublished - Apr 2013
Externally publishedYes

Fingerprint

Risk Management
Neoplasms
Health Care Costs
Health
Population
Delivery of Health Care
Taxes
Early Detection of Cancer
Uterine Cervical Neoplasms
Computer Simulation
Cost-Benefit Analysis
Canada
Economics
Demography
Outcome Assessment (Health Care)
Parturition
Breast Neoplasms
Lung

Keywords

  • Cancer
  • Policy tool
  • Simulation model

ASJC Scopus subject areas

  • Health Policy

Cite this

Evans, W. K., Wolfson, M. C., Flanagan, W. M., Shin, J., Goffin, J., Miller, A. B., ... Ng, E. (2013). Canadian cancer risk management model: Evaluation of cancer control. International Journal of Technology Assessment in Health Care, 29(2), 131-139. https://doi.org/10.1017/S0266462313000044

Canadian cancer risk management model : Evaluation of cancer control. / Evans, William K.; Wolfson, Michael C.; Flanagan, William M.; Shin, Janey; Goffin, John; Miller, Anthony B.; Asakawa, Keiko; Earle, Craig; Mittmann, Nicole; Fairclough, Lee; Oderkirk, Jillian; Finès, Philippe; Gribble, Stephen; Hoch, Jeffrey S; Hicks, Chantal; Omariba, D. Walter R; Ng, Edward.

In: International Journal of Technology Assessment in Health Care, Vol. 29, No. 2, 04.2013, p. 131-139.

Research output: Contribution to journalArticle

Evans, WK, Wolfson, MC, Flanagan, WM, Shin, J, Goffin, J, Miller, AB, Asakawa, K, Earle, C, Mittmann, N, Fairclough, L, Oderkirk, J, Finès, P, Gribble, S, Hoch, JS, Hicks, C, Omariba, DWR & Ng, E 2013, 'Canadian cancer risk management model: Evaluation of cancer control', International Journal of Technology Assessment in Health Care, vol. 29, no. 2, pp. 131-139. https://doi.org/10.1017/S0266462313000044
Evans, William K. ; Wolfson, Michael C. ; Flanagan, William M. ; Shin, Janey ; Goffin, John ; Miller, Anthony B. ; Asakawa, Keiko ; Earle, Craig ; Mittmann, Nicole ; Fairclough, Lee ; Oderkirk, Jillian ; Finès, Philippe ; Gribble, Stephen ; Hoch, Jeffrey S ; Hicks, Chantal ; Omariba, D. Walter R ; Ng, Edward. / Canadian cancer risk management model : Evaluation of cancer control. In: International Journal of Technology Assessment in Health Care. 2013 ; Vol. 29, No. 2. pp. 131-139.
@article{4642336dacb64d949f9655ebfb93132e,
title = "Canadian cancer risk management model: Evaluation of cancer control",
abstract = "Objectives: The aim of this study was to develop a decision support tool to assess the potential benefits and costs of new healthcare interventions. Methods: The Canadian Partnership Against Cancer (CPAC) commissioned the development of a Cancer Risk Management Model (CRMM)-a computer microsimulation model that simulates individual lives one at a time, from birth to death, taking account of Canadian demographic and labor force characteristics, risk factor exposures, and health histories. Information from all the simulated lives is combined to produce aggregate measures of health outcomes for the population or for particular subpopulations. Results: The CRMM can project the population health and economic impacts of cancer control programs in Canada and the impacts of major risk factors, cancer prevention, and screening programs and new cancer treatments on population health and costs to the healthcare system. It estimates both the direct costs of medical care, as well as lost earnings and impacts on tax revenues. The lung and colorectal modules are available through the CPAC Web site (www.cancerview.ca/cancerrriskmanagement) to registered users where structured scenarios can be explored for their projected impacts. Advanced users will be able to specify new scenarios or change existing modules by varying input parameters or by accessing open source code. Model development is now being extended to cervical and breast cancers.",
keywords = "Cancer, Policy tool, Simulation model",
author = "Evans, {William K.} and Wolfson, {Michael C.} and Flanagan, {William M.} and Janey Shin and John Goffin and Miller, {Anthony B.} and Keiko Asakawa and Craig Earle and Nicole Mittmann and Lee Fairclough and Jillian Oderkirk and Philippe Fin{\`e}s and Stephen Gribble and Hoch, {Jeffrey S} and Chantal Hicks and Omariba, {D. Walter R} and Edward Ng",
year = "2013",
month = "4",
doi = "10.1017/S0266462313000044",
language = "English (US)",
volume = "29",
pages = "131--139",
journal = "International Journal of Technology Assessment in Health Care",
issn = "0266-4623",
publisher = "Cambridge University Press",
number = "2",

}

TY - JOUR

T1 - Canadian cancer risk management model

T2 - Evaluation of cancer control

AU - Evans, William K.

AU - Wolfson, Michael C.

AU - Flanagan, William M.

AU - Shin, Janey

AU - Goffin, John

AU - Miller, Anthony B.

AU - Asakawa, Keiko

AU - Earle, Craig

AU - Mittmann, Nicole

AU - Fairclough, Lee

AU - Oderkirk, Jillian

AU - Finès, Philippe

AU - Gribble, Stephen

AU - Hoch, Jeffrey S

AU - Hicks, Chantal

AU - Omariba, D. Walter R

AU - Ng, Edward

PY - 2013/4

Y1 - 2013/4

N2 - Objectives: The aim of this study was to develop a decision support tool to assess the potential benefits and costs of new healthcare interventions. Methods: The Canadian Partnership Against Cancer (CPAC) commissioned the development of a Cancer Risk Management Model (CRMM)-a computer microsimulation model that simulates individual lives one at a time, from birth to death, taking account of Canadian demographic and labor force characteristics, risk factor exposures, and health histories. Information from all the simulated lives is combined to produce aggregate measures of health outcomes for the population or for particular subpopulations. Results: The CRMM can project the population health and economic impacts of cancer control programs in Canada and the impacts of major risk factors, cancer prevention, and screening programs and new cancer treatments on population health and costs to the healthcare system. It estimates both the direct costs of medical care, as well as lost earnings and impacts on tax revenues. The lung and colorectal modules are available through the CPAC Web site (www.cancerview.ca/cancerrriskmanagement) to registered users where structured scenarios can be explored for their projected impacts. Advanced users will be able to specify new scenarios or change existing modules by varying input parameters or by accessing open source code. Model development is now being extended to cervical and breast cancers.

AB - Objectives: The aim of this study was to develop a decision support tool to assess the potential benefits and costs of new healthcare interventions. Methods: The Canadian Partnership Against Cancer (CPAC) commissioned the development of a Cancer Risk Management Model (CRMM)-a computer microsimulation model that simulates individual lives one at a time, from birth to death, taking account of Canadian demographic and labor force characteristics, risk factor exposures, and health histories. Information from all the simulated lives is combined to produce aggregate measures of health outcomes for the population or for particular subpopulations. Results: The CRMM can project the population health and economic impacts of cancer control programs in Canada and the impacts of major risk factors, cancer prevention, and screening programs and new cancer treatments on population health and costs to the healthcare system. It estimates both the direct costs of medical care, as well as lost earnings and impacts on tax revenues. The lung and colorectal modules are available through the CPAC Web site (www.cancerview.ca/cancerrriskmanagement) to registered users where structured scenarios can be explored for their projected impacts. Advanced users will be able to specify new scenarios or change existing modules by varying input parameters or by accessing open source code. Model development is now being extended to cervical and breast cancers.

KW - Cancer

KW - Policy tool

KW - Simulation model

UR - http://www.scopus.com/inward/record.url?scp=84876527066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876527066&partnerID=8YFLogxK

U2 - 10.1017/S0266462313000044

DO - 10.1017/S0266462313000044

M3 - Article

C2 - 23514623

AN - SCOPUS:84876527066

VL - 29

SP - 131

EP - 139

JO - International Journal of Technology Assessment in Health Care

JF - International Journal of Technology Assessment in Health Care

SN - 0266-4623

IS - 2

ER -